Oncolytic targeting of androgen-sensitive prostate tumor by the respiratory syncytial virus (RSV): consequences of deficient interferon-dependent antiviral defense

BACKGROUND: Oncolytic virotherapy for cancer treatment utilizes viruses for selective infection and death of cancer cells without any adverse effect on normal cells. We previously reported that the human respiratory syncytial virus (RSV) is a novel oncolytic virus against androgen-independent PC-3 h...

Descripción completa

Detalles Bibliográficos
Autores principales: Echchgadda, Ibtissam, Chang, Te-Hung, Sabbah, Ahmed, Bakri, Imad, Ikeno, Yuji, Hubbard, Gene B, Chatterjee, Bandana, Bose, Santanu
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3038980/
https://www.ncbi.nlm.nih.gov/pubmed/21276246
http://dx.doi.org/10.1186/1471-2407-11-43

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3038980/
https://www.ncbi.nlm.nih.gov/pubmed/21276246
http://dx.doi.org/10.1186/1471-2407-11-43

Ejemplares similares